Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 6, 2000, Pages 557-562

  Krajinovic, Maja ^a   Richer, Chantal ^a   Sinnett, Hugues ^a   Labuda, Damian ^a,b   Sinnett, Daniel ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHILD; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACETYLTRANSFERASES; CASE-CONTROL STUDIES; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034094496     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dean, M. Cancer as a complex developmental disorder-nineteenth Cornelius P. Rhoads memorial award lecture. Cancer Res., 58: 5633-5636, 1998.
2. Champlin, R., and Gale, R. P. Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood, 73: 2051, 1989.
3. Linet, M. S. (ed.), The Leukemias: Epidemiologic Aspects. New York: Oxford University Press, 1985.
4. Pendergrass, T. W. Epidemiology of acute lymphoblastic leukaemia. Semin. Oncol., 12: 80, 1985.
5. Greaves, M. F. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia, 2: 120-125, 1986.
6. Perera, F. P. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst., 88: 496-509, 1996.
7. Whyatt, R. M., and Perera, F. P. Application of biologic markers to studies of environmental risks in children and the developing fetus. Environ. Health Perspect., 103: 105-110, 1995.
8. Perera, F. P., Jedrychowski, W., Rauh, V., and Whyatt, R. M. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ. Health Perspect., 107: 451-460, 1999.
9. Perera, F. P. Environment and cancer: who are susceptible? Science (Washington DC), 278: 1068-1073, 1997.
10. Krajinovic, M., Labuda, D., Richer, C., Karimi, S., and Sinnett, D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYPIA1, CYP2D6, GSTM1 and CSTT1 genetic polymorphisms. Blood, 93: 1496-1501, 1999.
11. Deloménie, C., Grant, D. M., Krishnamoorthy, R., and Dupret, J. M. Les arylamine N-acétyltransferases: génétique à la susceptibilité aux xénobiotiques. Médecine/Sciences, 14: 27-36, 1998.
12. Meyer, U. A., and Zanger, U. M. Molecular mechanism of genetic polymorphism of drug metabolism. Ann. Rev. Pharmacol. Toxicol., 37: 269-296, 1997.
13. Brockmoller, J., Cascorbi, I., Kerb, R., and Roots, I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res., 56: 3915-3925, 1996.
14. Cascorbi, I., Brockmoller, J., Mrozikiewicz, M., Bauer, S., Loddenkemper, R., and Roots, I. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res., 56: 3961-3966, 1996.
15. Hughes, N. C., Janezic, S. A., McQueen, K. L., Jewett, M. A., Castranio, T., Bell, D. A., and Grant, D. M. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective functions using p-aminosalicylate as an in-vivolin-vitro probe. Pharmacogenetics, 8: 55-66, 1998.
16. Bell, D. A., Stephens, A., Castranio, T., Umbach, D. M., Watson, M., Deakin, M., Elder, J., Hendrickse, C., Duncan, H., and Strange, C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55: 3537-3542, 1995.
17. Ambrosone, C. B., Freudenheim, J. L. Graham, S., Marshall, R. R., Vena, J. E., Brasure, J. R., Michalek, A. M., Laughlin, R., Nemoto, T., Gillenwater, K. A., Harrington, A. M., and Shields, P. G. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J. Am. Med. Assoc., 276. 1494-1501, 1996.
18. Drozdz, M., Gierek, T., Jendryczko, A., Pilch, J., and Piekarska, J. N-Acetyltransferase phenotype of patients with cancer of the larynx. Neoplasma, 34: 481-484, 1987.
19. Gonzales, M. V., Alvarez, V., Pello, M. F., Menendez, M. J., Suarez, C., and Coto, E. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J. Clin. Pathol., 4: 294-298, 1998.
20. Mommsen, S., Barfod, N. M., and Aagaard, J. N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population. Carcinogenesis (Lond.), 6: 199-201, 1985.
21. Risch, A., Wallace, D. M., Bathers, S., and Sim, E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet., 4: 231-236, 1995.
22. Chen, J., Stampfer, M. J., Hough, H. L., Garcia-Closas, M., Willett, W. C., Hennekens, C. H., Kelsey, K. T., and Hunter, D. J. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res., 58: 3307-3311, 1998.
23. Millikan, R. C., Pittman, G. S., Newman, B., Tse, C-K, J., Selmin, O., Rockhill, B., Savitz, D., Moorman, P. G., and Bell, D. A. Cigarette smoking, N-acetyltransferase 1 and 2 and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 7: 371-378, 1998.
24. Agundez, J. A., Ladero, J. M., Olivera, M., Abildua, R., Roman, J. M., and Benitez, J. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology, 52: 7-11, 1995.
25. Hirvonen, A., Pelin, K., Tammilehto, L., Karjalainen, A., Mattson, K., and Linnainmaa, K. Inherited CSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res., 55: 2981-2983, 1995.
26. Labuda, D., Zietkiewicz, E., and Labuda, M. The genetic clock and the age of the founder effect in growing populations: a lesson from French Canadians and Ashkenazim. Am. J. Hum. Genet., 61: 768, 1997.
27. Bouchard, G., and De Braekeleer, M. (eds.) Histoire d'un génome. Québec: Presses de l'Université du Québec, 1990.
28. Baccichet, A., Qualman, S. K., and Sinnett, D. Allelic loss in childhood acute lymphoblastic leukemia. Leuk. Res., 21: 817-823, 1997.
29. Labuda, D., Krajinovic, M., Richer, C., Skoll, A., Sinnett, H, Yotova, V., and Sinnett, D. Rapid detection of CYPIA1, CYP2D6, NAT variants by multiplex-PCR and allele-specific oligonucleotide assay Anal. Biochem. 275: 84-92: 1999.
30. Deitz, A. C., Doll, M. A., and Hein, D. W. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal. Biochem., 253: 219-224, 1997.
31. Henning, S., Cascorbi, I., Münchow, B., Jahnke, V., and Roots, I. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics, 9: 103-111, 1999.
32. Taylor, J. A., Umbach, D. M., Stephens, E., Castranio, T., Paulson, D., Robertson, C., Mohler, J. L., and Bell, D. A. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res., 58: 3603-3610, 1998.
33. Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P., and Kadlubar, F. F., Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55: 5230-5237, 1995.
34. Probst-Hensch, N. M., Haile, R. W., Li, D. S., Sakanoto, G. T., Louie, A. D., Lin, B. K., Frankl, H. D., Lee, E. R., and Lin, H. J. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis (Lond.), 17: 2125-2129, 1996.
35. Grant, D., Hughes, N., Janezic, S., Goodfellow, G., Chen, H., Gaedigk, A., Yu, V., and Grewal, R. Human acetyltransferase polymorphisms. Mutat. Res., 376: 61-70, 1997.
36. 560A mutations. Pharmacogenetics, 8: 67-72, 1998.
37. Neglia, J. P., and Robison, L. L. Epidemiology of the childhood acute leukemias. Pediatr. Clin. North Am., 35: 675-692, 1988.
38. Linet, M. S., and Devesa, S. S. Descriptive epidemiology of childhood leukaemia. Br. J. Cancer, 63: 424-429, 1991.
39. Infante-Rivard, C., Labuda, D., Krajinovic, M., and Sinnett, D. Childhood leukemia: risk associated with exposure to pesticides and with gene polymorphisms. Epidemiology, 10: 481-487, 1999.
40. Smelt, V. A., Mardon, H. J., and Sim, E. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol. Toxicol., 83: 149-157, 1998.
41. Derewlany, L. O., Knie, B., and Koren, G. Arylamine N-acetyltransferase activity of the human placenta. J. Pharmacol. Exp. Ther., 269: 756-760, 1994.
42. Pacifici, G. M., Bencini, C., and Rane, A. Acetyltransferase in human development and tissue distribution. Pharmacology, 32: 283-291, 1986.
43. Cribb, A. E., Grant, D. M., Miller, M. A., and Spielberg, S. P. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. J. Pharmacol. Exp. Ther. 259: 1241-1246, 1991.
44. Grant, D. M. Molecular genetics of the N-acetyltransferases. Pharmacogenetics, 3: 45-50, 1993.
45. Hirvonen, A., Saarikoski, S. T., Linnainmaa, K., Koskinen, K., Husgafvel-Pursiainen, K., Mattson, K., and Vainio, H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst., 88: 1853-1856, 1996.
46. MacLeod, S., Sinha, R., Kadlubar, F. F., and Lang, N. P. Polymorphisms of CYPIA1 and GSTM1 influence the in vivo function of CYPIA1. Mutat. Res., 376: 135-142, 1997.